Plasma exchange (PE)
Plasma exchange (PE) is a medical procedure with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Plasma Exchange in Pediatric Autoimmune Encephalitis
Plasma Exchange in Children With Severe Sepsis and Septic Shock
Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Clinical Trials (8)
Plasma Exchange in Pediatric Autoimmune Encephalitis
Plasma Exchange in Children With Severe Sepsis and Septic Shock
Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
CPI Combination Therapy for Autoimmune Encephalitis
A Clinical Trial With KJ103 in Anti-GBM Disease
Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
All 8 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 8